Close Menu

NEW YORK — Stratify Genomics, a maker of genetic-based cancer risk tests, said on Wednesday that it has raised $2.2 million in seed funding from undisclosed angel investors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.